Alpha-fetoprotein is a protein found in people with liver disease. Alpha-fetoprotein is also a "tumor marker" that can be used to determine if a patient has liver cancer (liver cancer is also known as hepatocellular carcinoma).

Cancer screening is a cancer prevention measure for asymptomatic "healthy people", that is, when the body is not abnormal discomfort, take the initiative to do relevant examinations, the purpose is to find early cancer and precancerous lesions, to achieve early detection and early diagnosis and early treatment.

The clinical application of alpha-fetoprotein (AFP) detection project holds significant importance in healthcare. AFP is a protein produced by the liver during fetal development, and its levels can be abnormal in certain diseases, including liver cancer and certain birth defects.

In recent years, the screening of alpha-fetoprotein (AFP) for liver cancer has attracted wides attention. AFP is a biomarker for liver cancer. It can help doctors detecting liver cancer earlier and improve treatment success rates by detecting levels of AFP in blood.